InvestorsHub Logo
Followers 51
Posts 3072
Boards Moderated 9
Alias Born 01/28/2001

Re: oldstocks post# 19

Wednesday, 11/15/2023 11:41:11 AM

Wednesday, November 15, 2023 11:41:11 AM

Post# of 64
Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(0.07) per share. This is a 22.22 percent increase over losses of $(0.09) per share from the same period last year.
Write to Benzinga at editorial@benzinga.com
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVKD News